tirzepatide cnn China Clears Eli Lilly's Weight Loss Drug Tirzepatide, Only For Diabetes FDA says shortage of GLP-1

This makes it uniquely effective for: Visceral fat reduction (glucagon is specifically active on abdominal fat stores) Resting metabolic rate increase (glucagon is thermogenic it raises your metabolic baseline) Food noise suppression (GLP-1 component dampens reward-driven eating) Satiety signaling (GIP + GLP-1 extend fullness after meals) Because of this third mechanism, the clinical trial results for Retatrutide are notably better than other approved GLP-1s for body weight reduction

Schedule a new patient consultation so we can review your goals and health history and create a personalized plan for safe, lasting weight loss

Eli Lilly is also conducting a phase-3 trial called SURPASS-CVOT, which explores the potential benefits of tirzepatide for cardiovascular health in T2D patients [9]

Diabesity is a complex, multifactorial condition that poses significant health risks, including cardiovascular disease, diabetes, and certain cancers